These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28856542)

  • 1. Imaging behavioural complications of Parkinson's disease.
    Valli M; Mihaescu A; Strafella AP
    Brain Imaging Behav; 2019 Apr; 13(2):323-332. PubMed ID: 28856542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies.
    Wen MC; Chan LL; Tan LC; Tan EK
    Eur J Neurol; 2016 Jun; 23(6):1001-19. PubMed ID: 27141858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.
    Sierra M; Carnicella S; Strafella AP; Bichon A; Lhommée E; Castrioto A; Chabardes S; Thobois S; Krack P
    J Parkinsons Dis; 2015; 5(3):625-36. PubMed ID: 25870025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of psychiatric symptoms and global cognition in early Parkinson disease.
    de la Riva P; Smith K; Xie SX; Weintraub D
    Neurology; 2014 Sep; 83(12):1096-103. PubMed ID: 25128183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric Issues in Parkinson's Disease.
    Cooney JW; Stacy M
    Curr Neurol Neurosci Rep; 2016 May; 16(5):49. PubMed ID: 27048443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment.
    Thobois S; Prange S; Sgambato-Faure V; Tremblay L; Broussolle E
    Curr Neurol Neurosci Rep; 2017 Aug; 17(10):76. PubMed ID: 28822071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis, apathy, depression and anxiety in Parkinson's disease.
    Gallagher DA; Schrag A
    Neurobiol Dis; 2012 Jun; 46(3):581-9. PubMed ID: 22245219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separate neural representations of depression, anxiety and apathy in Parkinson's disease.
    Dan R; Růžička F; Bezdicek O; Růžička E; Roth J; Vymazal J; Goelman G; Jech R
    Sci Rep; 2017 Sep; 7(1):12164. PubMed ID: 28939804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson's Disease.
    Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
    J Parkinsons Dis; 2015; 5(3):541-8. PubMed ID: 26406134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric Symptoms in Parkinson's Disease.
    Aarsland D; Kramberger MG
    J Parkinsons Dis; 2015; 5(3):659-67. PubMed ID: 26406147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of neuropsychiatric disorders in drug-naive subjects with Parkinson's disease (PD)].
    Isais-Millán S; Piña-Fuentes D; Guzmán-Astorga C; Cervantes-Arriaga A; Rodríguez-Violante M
    Gac Med Mex; 2016; 152(3):357-63. PubMed ID: 27335192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric syndromes in Parkinson's disease.
    Starkstein SE; Brockman S; Hayhow BD
    Curr Opin Psychiatry; 2012 Nov; 25(6):468-72. PubMed ID: 22992542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease.
    D'Iorio A; Vitale C; Piscopo F; Baiano C; Falanga AP; Longo K; Amboni M; Barone P; Santangelo G
    Parkinsonism Relat Disord; 2017 Oct; 43():114-117. PubMed ID: 28797564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.
    Trojano L; Papagno C
    Neurol Sci; 2018 Jan; 39(1):53-61. PubMed ID: 29038946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmasking neurobiological commonalities between addictive disorders and impulse control disorders in Parkinson's disease.
    Ramdave S; Dawson A; Carter A; Dissanayaka NNW
    Brain Imaging Behav; 2020 Dec; 14(6):2785-2798. PubMed ID: 30707344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Imaging and Impulse Control Disorders in Parkinson's Disease.
    Roussakis AA; Lao-Kaim NP; Piccini P
    Curr Neurol Neurosci Rep; 2019 Aug; 19(9):67. PubMed ID: 31396719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural disorders, disability and quality of life in Parkinson's disease.
    Leroi I; Ahearn DJ; Andrews M; McDonald KR; Byrne EJ; Burns A
    Age Ageing; 2011 Sep; 40(5):614-21. PubMed ID: 21788252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of apathy with central fatigue perception in patients with Parkinson's disease.
    Sáez-Francàs N; Hernández-Vara J; Corominas Roso M; Alegre Martín J; Casas Brugué M
    Behav Neurosci; 2013 Apr; 127(2):237-44. PubMed ID: 23339489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.